Healthcare Services

A Significant Growth Driver for the Bartonellosis Market Is the Impact Of Rising Zoonotic Disease Incidences On The Market Growth

March 30, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Bartonellosis Market Between 2026 And 2030?

The bartonellosis market size has demonstrated rapid expansion in recent years. This market is set to expand from $1.3 billion in 2025 to $1.46 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.7%. The market’s past growth is primarily due to factors such as an escalating incidence of cat scratch disease, enhanced diagnostic capabilities for infectious diseases, the provision of antibiotic therapies, the enlargement of hospital diagnostic laboratories, and growing awareness of bartonella infections among clinicians.

The bartonellosis market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $2.24 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.3%. This anticipated growth during the forecast period stems from factors such as the accelerated development of rapid diagnostic tests, a heightened emphasis on prompt intervention for systemic infections, the broadening of specialized infectious disease treatment services, the increasing embrace of precise antibiotic treatment plans, and greater investment in research related to zoonotic diseases. Key trends foreseen during the forecast timeframe encompass the increasing integration of molecular diagnostic methodologies, a surge in the application of PCR-based testing, heightened public understanding of zoonotic infections, the broadening scope of targeted antibiotic treatment guidelines, and an intensified focus on identifying diseases at early stages.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21111&type=smp

What Drivers Are Influencing The Bartonellosis Market?

The increasing occurrence of zoonotic diseases is projected to stimulate the growth of the bartonellosis market moving forward. These illnesses are characterized by their transmission from animals to humans, either directly or through vectors. The surge in zoonotic disease incidences is attributed to factors such as heightened human-animal interactions, environmental alterations, deforestation, global travel, and the spread of pathogens across various species. Bartonellosis exemplifies zoonotic diseases by illustrating how bacterial pathogens, transmitted via animal vectors like fleas, ticks, and lice, can infect humans, leading to a variety of clinical manifestations and underscoring the critical importance of understanding vector-borne disease transmission in public health. As an illustration, in December 2024, the European Food Safety Authority (EFSA) and European Centre for Disease Prevention and Control (ECDC), a Europe-based public health authority, reported that human campylobacteriosis cases escalated to 148,181, indicating a 4.3% year-over-year rise from 139,225 cases in 2022. Similarly, salmonellosis cases climbed to 77,486, representing a 16.9% growth compared to 65,478 cases in 2022. Thus, the escalating incidence of zoonotic diseases is propelling the expansion of the bartonellosis market.

Which Market Segments Are Examined In The Bartonellosis Market Study?

The bartonellosis market covered in this report is segmented –

1) By Disease Type: Cat Scratch Disease (CSD), Trench Fever, Bartonella Endocarditis, Other Disease Types

2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing, Serological Testing, Culture Methods, Histological Testing

3) By Treatment: Antibiotics, Antibacterial Agents, Supportive Care

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Cat Scratch Disease (CSD): Immunocompetent Hosts, Immunocompromised Hosts, Neurological Complications

2) By Trench Fever: Acute Trench Fever, Chronic Trench Fever, Asymptomatic Infections

3) By Bartonella Endocarditis: Native Valve Endocarditis, Prosthetic Valve Endocarditis, Bloodstream Infections

4) By Other Disease Types: Bacillary Angiomatosis, Parinaud’s Oculoglandular Syndrome, Bartonella-associated Vasculitis

What Industry Trends Are Redefining The Bartonellosis Market?

Key players in the Bartonellosis market are prioritizing technological progress, such as multi-microbial phage modulation, to secure a competitive edge. This multi-microbial phage modulation entails employing tailored phage cocktails designed to simultaneously target several intracellular pathogens, thereby tackling co-infections which often complicate therapies for Bartonella. As an example, during November 2024, Biologix Center, a US-based biotechnology firm, unveiled Induced Native Phage Cocktails specifically developed for individuals suffering from Bartonella and Babesia co-infections. This treatment offers pathogen-specific activation of phages, daily adaptive dosing customized according to patient microbial profiles, and improved access to areas where persistent infections reside. Such an innovation facilitates a holistic strategy for intricate co-infections, lessens reliance on traditional antibiotics, and champions precision medicine methodologies. Through the utilization of multi-microbial phage therapy, firms are developing individualized treatment options within the Bartonellosis market, all while managing the clinical validation and regulatory processes typical for novel biologic treatments.

Who Are The Primary Competitors In The Bartonellosis Market?

Major companies operating in the bartonellosis market are Mayo Clinic Laboratories, Northwell Health Labs, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., Alberta Precision Laboratories, Jiangsu BioPerfectus Technologies Co. Ltd., ARUP Laboratories, Surmodics Inc., Medical Diagnostic Laboratories LLC, Creative Biolabs, IGeneX Inc., Karius Inc., Synnovis Group LLP, Galaxy Diagnostics Inc., Gold Standard Diagnostics, Eurofins Biomnis, AMMAGENOMICS Private Limited, Ringbio

Read the full bartonellosis market report here:

https://www.thebusinessresearchcompany.com/report/bartonellosis-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Bartonellosis Market?

North America was the largest region in the bartonellosis market in 2025. The regions covered in the bartonellosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Bartonellosis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21111&type=smp

Browse Through More Reports Similar to the Global Bartonellosis Market 2026, By The Business Research Company

Esophageal Cancer Global Market Report

https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report

Esophageal Dysphagia Global Market Report

https://www.thebusinessresearchcompany.com/report/esophageal-dysphagia-global-market-report

Animal Gastroesophageal Reflux Disease Global Market Report

https://www.thebusinessresearchcompany.com/report/animal-gastroesophageal-reflux-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795